Loading…
Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases...
Saved in:
Published in: | Journal of advanced pharmaceutical technology and research 2020-07, Vol.11 (3), p.113-116 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3 |
---|---|
cites | |
container_end_page | 116 |
container_issue | 3 |
container_start_page | 113 |
container_title | Journal of advanced pharmaceutical technology and research |
container_volume | 11 |
creator | Ramdhani, Danni Azizah, Shinta Kusuma, Sri Sediana, Dede |
description | Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs. |
doi_str_mv | 10.4103/japtr.JAPTR_17_20 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A629933650</galeid><doaj_id>oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e</doaj_id><sourcerecordid>A629933650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</originalsourceid><addsrcrecordid>eNp9kt1u00AQhS0EolHpA3CDVuKGi6bsr3-4QIqiQoMqgVC5Xo3X43YTxxt21w15Ex6XddOWFgH2heWd7xx7Zk6WvWT0RDIq3i5hE_3Jp9mXi6-aFZrTJ9mEVkU-5bSST7MJ54JNJZX0IDsKYUnTJSpecPU8OxCCUc4qMcl-zvpoa-uiNcRjsCFCb_AdOb2GboBoXU9cSzq8dm3nfoCxPYkeIa6xjyS9gBkijsqN9RCd36UymLHUohnlgRgIGAhEEq-QXECwqzV0sAMyt3FHzhC6eEXmyQ_9MVn0jevTf8CL7FkLXcCj2-dh9u3D6cX8bHr--eNiPjufmlyWcSpZQZnBtmkrSU1jmKF50aAAalK7ZQkUW9pSJopWqsoIzMuyQllzgwiUozjMFnvfxsFSb7xdg99pB1bfHDh_qcGn6XSopeFVDbVSRc5lY1SFtSpBqVLWyLkcvd7vvTZDvcbGpJ48dI9MH1d6e6Uv3bUuVCELwZLBm1sD774PGKJe22Cw66BHNwTNpZKSMcZVQl__gS7d4Ps0Kp2qPK_S_ov_UpLLUilJ-W_qElKbaXVuXOL4aT3LeVUJkSuaqJO_UOlucG1N2lpr0_kjAdsLjHcheGzvJ8GoHjOsbzKsH2Q4aV49HOG94i6xCZjvga3rUmLCqhu26HViV73b_ttZMyb0XdjFL3R0B_I</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532692237</pqid></control><display><type>article</type><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><source>PubMed Central</source><creator>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</creator><creatorcontrib>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</creatorcontrib><description>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</description><identifier>ISSN: 2231-4040</identifier><identifier>EISSN: 0976-2094</identifier><identifier>DOI: 10.4103/japtr.JAPTR_17_20</identifier><identifier>PMID: 33102193</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>acute respiratory tract infections ; Analysis ; Antibiotic resistance ; Antibiotics ; Bacteria ; Clinical isolates ; Conflicts of interest ; Drug resistance ; Drug therapy ; Gram-negative bacteria ; Gram-positive bacteria ; Health aspects ; Identification ; Infection ; Infections ; Lactose ; Levofloxacin ; Medical research ; Microbial drug resistance ; Morphology ; Mortality ; Motility ; Original ; Parenchyma ; Patient compliance ; Patients ; Physiology ; Respiratory diseases ; Respiratory tract diseases ; Respiratory tract infection ; Sensitivity analysis ; Streptococcus infections ; Urban health</subject><ispartof>Journal of advanced pharmaceutical technology and research, 2020-07, Vol.11 (3), p.113-116</ispartof><rights>Copyright: © 2020 Journal of Advanced Pharmaceutical Technology & Research.</rights><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2020 Journal of Advanced Pharmaceutical Technology & Research 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33102193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramdhani, Danni</creatorcontrib><creatorcontrib>Azizah, Shinta</creatorcontrib><creatorcontrib>Kusuma, Sri</creatorcontrib><creatorcontrib>Sediana, Dede</creatorcontrib><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><title>Journal of advanced pharmaceutical technology and research</title><addtitle>J Adv Pharm Technol Res</addtitle><description>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</description><subject>acute respiratory tract infections</subject><subject>Analysis</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Clinical isolates</subject><subject>Conflicts of interest</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Gram-negative bacteria</subject><subject>Gram-positive bacteria</subject><subject>Health aspects</subject><subject>Identification</subject><subject>Infection</subject><subject>Infections</subject><subject>Lactose</subject><subject>Levofloxacin</subject><subject>Medical research</subject><subject>Microbial drug resistance</subject><subject>Morphology</subject><subject>Mortality</subject><subject>Motility</subject><subject>Original</subject><subject>Parenchyma</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Physiology</subject><subject>Respiratory diseases</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Sensitivity analysis</subject><subject>Streptococcus infections</subject><subject>Urban health</subject><issn>2231-4040</issn><issn>0976-2094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kt1u00AQhS0EolHpA3CDVuKGi6bsr3-4QIqiQoMqgVC5Xo3X43YTxxt21w15Ex6XddOWFgH2heWd7xx7Zk6WvWT0RDIq3i5hE_3Jp9mXi6-aFZrTJ9mEVkU-5bSST7MJ54JNJZX0IDsKYUnTJSpecPU8OxCCUc4qMcl-zvpoa-uiNcRjsCFCb_AdOb2GboBoXU9cSzq8dm3nfoCxPYkeIa6xjyS9gBkijsqN9RCd36UymLHUohnlgRgIGAhEEq-QXECwqzV0sAMyt3FHzhC6eEXmyQ_9MVn0jevTf8CL7FkLXcCj2-dh9u3D6cX8bHr--eNiPjufmlyWcSpZQZnBtmkrSU1jmKF50aAAalK7ZQkUW9pSJopWqsoIzMuyQllzgwiUozjMFnvfxsFSb7xdg99pB1bfHDh_qcGn6XSopeFVDbVSRc5lY1SFtSpBqVLWyLkcvd7vvTZDvcbGpJ48dI9MH1d6e6Uv3bUuVCELwZLBm1sD774PGKJe22Cw66BHNwTNpZKSMcZVQl__gS7d4Ps0Kp2qPK_S_ov_UpLLUilJ-W_qElKbaXVuXOL4aT3LeVUJkSuaqJO_UOlucG1N2lpr0_kjAdsLjHcheGzvJ8GoHjOsbzKsH2Q4aV49HOG94i6xCZjvga3rUmLCqhu26HViV73b_ttZMyb0XdjFL3R0B_I</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Ramdhani, Danni</creator><creator>Azizah, Shinta</creator><creator>Kusuma, Sri</creator><creator>Sediana, Dede</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200701</creationdate><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><author>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>acute respiratory tract infections</topic><topic>Analysis</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Clinical isolates</topic><topic>Conflicts of interest</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Gram-negative bacteria</topic><topic>Gram-positive bacteria</topic><topic>Health aspects</topic><topic>Identification</topic><topic>Infection</topic><topic>Infections</topic><topic>Lactose</topic><topic>Levofloxacin</topic><topic>Medical research</topic><topic>Microbial drug resistance</topic><topic>Morphology</topic><topic>Mortality</topic><topic>Motility</topic><topic>Original</topic><topic>Parenchyma</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Physiology</topic><topic>Respiratory diseases</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Sensitivity analysis</topic><topic>Streptococcus infections</topic><topic>Urban health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramdhani, Danni</creatorcontrib><creatorcontrib>Azizah, Shinta</creatorcontrib><creatorcontrib>Kusuma, Sri</creatorcontrib><creatorcontrib>Sediana, Dede</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of advanced pharmaceutical technology and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramdhani, Danni</au><au>Azizah, Shinta</au><au>Kusuma, Sri</au><au>Sediana, Dede</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</atitle><jtitle>Journal of advanced pharmaceutical technology and research</jtitle><addtitle>J Adv Pharm Technol Res</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>11</volume><issue>3</issue><spage>113</spage><epage>116</epage><pages>113-116</pages><issn>2231-4040</issn><eissn>0976-2094</eissn><abstract>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>33102193</pmid><doi>10.4103/japtr.JAPTR_17_20</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2231-4040 |
ispartof | Journal of advanced pharmaceutical technology and research, 2020-07, Vol.11 (3), p.113-116 |
issn | 2231-4040 0976-2094 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e |
source | PubMed Central |
subjects | acute respiratory tract infections Analysis Antibiotic resistance Antibiotics Bacteria Clinical isolates Conflicts of interest Drug resistance Drug therapy Gram-negative bacteria Gram-positive bacteria Health aspects Identification Infection Infections Lactose Levofloxacin Medical research Microbial drug resistance Morphology Mortality Motility Original Parenchyma Patient compliance Patients Physiology Respiratory diseases Respiratory tract diseases Respiratory tract infection Sensitivity analysis Streptococcus infections Urban health |
title | Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A49%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20resistance:%20Evaluation%20of%20levofloxacin%20treatment%20in%20acute%20respiratory%20tract%20infections%20cases%20at%20the%20Tasikmalaya%20City%20Health%20Center,%20Indonesia&rft.jtitle=Journal%20of%20advanced%20pharmaceutical%20technology%20and%20research&rft.au=Ramdhani,%20Danni&rft.date=2020-07-01&rft.volume=11&rft.issue=3&rft.spage=113&rft.epage=116&rft.pages=113-116&rft.issn=2231-4040&rft.eissn=0976-2094&rft_id=info:doi/10.4103/japtr.JAPTR_17_20&rft_dat=%3Cgale_doaj_%3EA629933650%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532692237&rft_id=info:pmid/33102193&rft_galeid=A629933650&rfr_iscdi=true |